Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 25, 2012
ISPE announced today that it has brought together a substantial line-up of global regulatory officials and pharmaceutical industry leaders to be plenary speakers at the FDA/ISPE co-sponsored “Redefining the ‘C’ in ‘CGMP’” Conference in Baltimore, Md....
read more
The European Commission (EC) has granted marketing authorization in the European Union (EU) for FLIXABI®, an infliximab biosimilar referencing Remicade®i.
read more
Thursday, November 30, 2017
Pharmaceutical Product Development (PPD) announced it earned two honors for excellence in regulatory affairs at the TOPRA Awards in London.
read more
Tuesday, December 02, 2025
Rentschler Biopharma and Coriolis Pharma announced a strategic collaboration which will offer seamless, end-to-end solutions from early formulation through to commercial manufacturing, combining their complementary expertise to accelerate product’s ...
read more
Friday, November 21, 2014
The biotech sector in the Greater Munich area continues to demonstrate significant growth in revenue and staff numbers despite ever-increasing international competition. This continues Munich's status as one of the pre-eminent locations for this ...
read more
Friday, November 20, 2015
The U.S. Food and Drug Administration has approved Narcan nasal spray, the first FDA-approved nasal spray version of naloxone hydrochloride, a life-saving medication that can stop or reverse the effects of an opioid overdose.
read more
Kemwell Biopharma announced it has manufactured and supplied drug substance in India for clinical trials that will be performed by its customer in USA for an IND filing.
read more
Wednesday, August 20, 2025
ChemPartner announced its strategic expansion in the U.S. with the upcoming opening of the ChemPartner Boston Center of Excellence in Watertown, MA. The new R&D site will commence operations on September 10, 2025, providing discovery and preclinical ...
read more
Aptuit LLC announced that the company has innovated a translational strategy that represents a unique approach, known as “Complementary Vision,” for those in search of high value Chemistry, Manufacturing and Control (CMC) services.
read more
Friday, December 01, 2017
At the FDA, we’re vigilant about helping address the challenges that remain.
read more
Altasciences has announced the appointment of Dr. Joseph A. Francisco as Chief Toxicologist.
read more
Symbiosis has successfully completed a scheduled inspection by the UK Government regulator, the MHRA.
read more
Tuesday, December 01, 2015
Optimal Research, a clinical research site solution provider, has announced the addition of a 40 bed Phase I inpatient facility in Austin, TX.
read more
KBI Biopharma has completed the acquisition of the assets of Elion Labs, a contract services organization in Louisville, CO.
read more
Kincell Bio, a CDMO focused on cell therapies, received $36 million in new funding. Kineticos Ventures led Kincell’s launch funding.
read more